Tesla (TSLA) buys Maxwell Technologies (MXWL) in 2019

February 4, 2019 - Tesla (TSLA) announced plans to buy Maxwell Technologies (MXWL) this morning for roughly $4.75 per share.  This is about a 50% premium to Friday's close.

Why is Tesla (TSLA) buying Maxwell (MXWL) for $218 Million?

Maxwell Tech (MXWL) makes ultracapacitors that are used in automobile batteries to lengthen their lives. They are also used for electric energy storage on power grids.  Maxwell has a vast patent portfolio and Tesla is paying a discount with today's share price vs the $12-$14 per share back in 2014.  From 2016-2018, shares traded in a range between $4.25 and $6.50.

It is very clear, Elon Musk likes Maxwell's technology!

Landry's buys McCormick & Schmick's Seafood Restaurants, Inc. (MSSR)

By Tim - http://blackberrystocks.com

November 8, 2011 - By Tim - McCormick & Schmick's Seafood Restaurants, Inc. (MSSR) is getting bought out today by Landry's, just 12 hours after the company reported a huge earnings miss. McCormick & Schmick's Seafood Restaurants, Inc. (MSSR) missed earnings by $0.13 and suspended guidance last night. Something doesn't smell right here. I didn't see the stock trade last night but I feel they should have announced the deal at that point, not this morning.

McCormick & Schmick's Seafood Restaurants, Inc. (MSSR) stock is trading up 28% in pre market to $8.67.

More Stock News

BlackberryStocks.com

StocksToBuy.org - Stock Forum

Tenet Healthcare Corp. (THC) Buyout Offer

By Tim - http://stockstobuy.org

Tenet Healthcare Corp. (THC) has received a buyout offer from Community Health Systems, Inc. (NYSE:CYH) for $6.00 per share. Tenet Healthcare Corp. (THC) is currently trading at $6.51 in pre market, up 52%.

Tenet Healthcare Corporation (NYSE:THC - News) today confirmed that it has received a proposal from Community Health Systems, Inc. (NYSE:CYH - News) to acquire all of the outstanding shares of Tenet for $6.00 per share in cash and stock.

Tenet noted that Community Health’s proposal is identical in all material respects to a Community Health proposal received by Tenet on November 12, 2010. The Tenet Board of Directors, after consultation with its financial and legal advisors, unanimously determined that the prior Community Health proposal was not in the best interests of Tenet or its shareholders. In making its determination, the Tenet Board considered that Community Health’s opportunistic proposal would transfer the growth potential inherent in Tenet to Community Health without adequately compensating Tenet shareholders. The Tenet Board believes that the interests of Tenet shareholders would be better served by benefiting from 100% of the upside inherent in Tenet rather than accepting Community Health’s inadequate proposal. In addition, the Board has serious concerns about Community Health’s ability to integrate and operate a business like Tenet.

The Tenet Board informed Community Health of its determination,

http://www.tenethealth.com/investors/pages/default.aspx

http://daytradingstockblog.blogspot.com

Radware Ltd. RDWR Stock Analysis 9/15/10 - Buyout??

By Tim - http://stockstobuy.org

The following is Radware Ltd. (RDWR) stock technical analysis for September 15, 2010

Radware Ltd. (RDWR) Support & Resistance Levels - 9/15/10

Resistance Levels: $40

Support Levels: $35, $30, $28

Chart - http://www.stockcharts.com/

Radware Ltd. (RDWR) stock has been spiking over the past two days on buyout speculation. Rumor has it HP or IBM is in talks to buy the company for $1 billion. If these rumors are true, share of Radware Ltd. would fetch a price of $45-$46 per share. RDWR fell to the low $35's in early trading today and then went on to spike up to $40. You can tell something is brewing due to the volume. If you plan to play Radware as a buyout candidate, I would start buying below $36. Keep in mind, if this stock doesn't get bought out, it could drift back below $28.

For more Technical Analysis - Go Here

Today's Biggest Stock Market Gainers - Top 2010 Stock Gainers - Top 2010 Penny Stocks - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Stocks for 2010

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/

Oracle Corp ORCL Buys Phase Forward Inc PFWD

By Tim - http://stockstobuy.org

Shares of Phase Forward Inc. (PFWD) are up 28% to $16.84 this morning as Oracle Corp. (ORCL) will be purchasing the company for $685 million.

Oracle Buys Phase Forward

Expands Oracle’s Solutions for the Life Sciences and Healthcare Industries

April 16, 2010 - Oracle announced today that it has agreed to acquire Phase Forward (NASDAQ: PFWD), a leading provider of applications for life sciences companies and healthcare providers, through a cash merger for $17.00 per share, or approximately $685 million.

Phase Forward’s SaaS-based Integrated Clinical Research Suite manages clinical development and safety processes from Phase 1 clinical trials through regulatory submission and post-approval monitoring. Adding complementary assets to Oracle Health Sciences, the combination is expected to enable researchers, clinical development professionals, physicians, regulators and patients to more effectively and securely capture, contribute, access and share data. The acquisition of Phase Forward is consistent with Oracle’s strategy to provide mission-critical applications for key industries. Full Press Release - Here


Today's Biggest Stock Gainers - Top 2010 Stock Gainers - Top 2010 Penny Stocks - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Stocks for 2010

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free

Disney DIS Buys Marvel MVL - 8/31/09

August 31, 2009 - Walt Disney Co. (DIS) has just announced that they will aquire Marvel Entertainment, Inc. (MVL)

Building on its strategy of delivering quality branded content to people around the world, The Walt Disney Company (NYSE:DIS) has agreed to acquire Marvel Entertainment, Inc. (NYSE:MVL) in a stock and cash transaction, the companies announced today.

DIS - Current Stock Price = $26.15 Down 2.15%
MVL Current Stock Price = $48.60 Up 25.75%

Under the terms of the agreement and based on the closing price of Disney on August 28, 2009, Marvel shareholders would receive a total of $30 per share in cash plus approximately 0.745 Disney shares for each Marvel share they own. At closing, the amount of cash and stock will be adjusted if necessary so that the total value of the Disney stock issued as merger consideration based on its trading value at that time is not less than 40% of the total merger consideration.
Based on the closing price of Disney stock on Friday, August 28, the transaction value is $50 per Marvel share or approximately $4 billion. Link

For More Stock Market Updates, visit , http://daytradingstockblog.blogspot.com/ or Subscribe for FREE

Merck MRK buys Schering-Plough SGP 3/9/09

The Dow Jones Futures are taking a bit of a nose dive as Dow component Merck ( MRK ) buys Schering-Plough ( SGP ) for 41.1 Billion today, 3/9/09.

• COMBINED COMPANY POSITIONED FOR SUSTAINABLE GROWTH THROUGH SCIENTIFIC INNOVATION AND A STRONGER, MORE DIVERSIFIED PRODUCT PORTFOLIO
  
• Powerful Joint R&D Pipeline with Strong Candidates in All Development Phases Doubles the Number of Late-Stage Compounds to 18
  
• Broader Product Portfolio in Critical Therapeutic Areas
  
• Expanded Global Presence Including High-Growth Emerging Markets
  
• Expected to be Significantly Accretive, Increase Efficiencies and Result in Cost Savings of Approximately $3.5 Billion Annually
  
• Merck Committed to Maintain Current Dividend

March 9, 2009 - Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that their Boards of Directors have unanimously approved a definitive merger agreement under which Merck and Schering-Plough will combine, under the name Merck, in a stock and cash transaction. Under the terms of the agreement, Schering-Plough shareholders will receive 0.5767 shares and $10.50 in cash for each share of Schering-Plough. Each Merck share will automatically become a share of the combined company. Merck Chairman, President and Chief Executive Officer Richard T. Clark will lead the combined company.

Based on the closing price of Merck stock on March 6, 2009, the consideration to be received by Schering-Plough shareholders is valued at $23.61 per share, or $41.1 billion in the aggregate. This price represents a premium to Schering-Plough shareholders of approximately 34 percent based on the closing price of Schering-Plough stock on March 6, 2009. The consideration also represents a premium of approximately 44 percent based on the average closing price of the two stocks over the last 30 trading days

Full Article

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free

Lehman LEH Afterhours, Aftermarket 9/11/08

Lehman ( LEH ) is trading at around $4.20 in afterhours tonight....down slightly from the $4.33 close during regular stock market trading on 9/11/08.

CNBC has been reporting that Lehman Brothers ( LEH ) is being shopped around Wall Street for a potential buyer of the company. Names that have come up are, B of A Bank of America, HSBC, and even Goldman Sachs ( GS ). GS would only likely being interested if the government backed certain debt and assets of Lehman Brothers.

CNBC's Charlie Gasparino thinks there is a chance that Lehman Brothers ( LEH ) will be bought out in a matter of days. It is important to note that Lehman has not accessed the Federal Reserves Discount Window recently.

SNDK - Sandisk: Samsung wants to buy Sandisk - 9/05/08

Samsung came out last night and stated that they mulling a way to buyout Sandisk ( SNDK ). I wonder how the shorts feel about this today as SNDK is up nearly 32% in pre market. This is what happens when stocks are dirt cheap!

South Korea's Samsung Electronics Co. (005930.SE) Friday said it is looking at various ways of tying up with SanDisk Corp. (SNDK), including a possible acquisition of the world's largest flash memory card maker by revenue.

Analysts said an acquisition, if it pushes through, could help Samsung cut the amount of royalties it pays to SanDisk, and could further tighten its control of the global flash memory market.
"We're looking at various tie-up plans with SanDisk, including an acquisition, but nothing has been decided for now," Samsung, the world's largest maker of memory chips by revenue and units, said in a regulatory filing.

Sandisk ( SNDK ) has come out this morning and say that they recieve a lot of offers but will not comment on rumors.

Roche buying DNA Genentech

Roche has offered to buy the rest of Genentech DNA for 43.7 Billion dollars. As you might know already, Roche already owns a 55.9 percent stake in DNA.

The Swiss drug maker Roche is offering $89 per share for the remaining DNA shares.

Genentech is trading above $96 in pre market so far this morning so it looks like their could be a taken over battle here. The market is pricing in a higher takeover price.

On another note, Merck MRK is postponing earnings until tonight at 4pm.